Back to Awarded Treatment Trials
Awarded Trial: 02T-135
Secondary Drug Intervention
Duration of Study Period for Each Subject
SADS-L, PANSS, SANS, BPRS, AIMS, cognitive battery
Eighteen patients were randomized to buspirone or placebo for 6 wks as adjunct medication. There were no significance differences between the two groups on measures of cognitive function or symptom rating.
Piskulic D, Olver JS, Maruff P, Norman TR. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist. Hum Psychopharmacol. 2009 Aug;24(6):437-46.
Department of Psychiatry
University of Melbourne
Austin and Repatriation Medical Centre
City or Town
State or Province
Zip or Postal Code